BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 4 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 5 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 6 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 18 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 18 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 21 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 23 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 1 day ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 day ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 4 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 5 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 6 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 18 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 18 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 21 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 23 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 1 day ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 day ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago
ADVERTISEMENT
AlphaGraphs

PG Earnings: Key quarterly highlights from Procter & Gamble’s Q1 2024 financial results

The Procter & Gamble Company (NYSE: PG) reported first quarter 2024 earnings results today. Net sales increased 6% year-over-year to $21.9 billion. Organic sales growth was 7%. Net earnings attributable to Procter & Gamble increased 15% to $4.5 billion while EPS rose 17% to $1.83. Core EPS also grew 17% to $1.83. Revenue and earnings […]

October 18, 2023 1 min read

The Procter & Gamble Company (NYSE: PG) reported first quarter 2024 earnings results today.

Net sales increased 6% year-over-year to $21.9 billion. Organic sales growth was 7%.

Net earnings attributable to Procter & Gamble increased 15% to $4.5 billion while EPS rose 17% to $1.83. Core EPS also grew 17% to $1.83.

Revenue and earnings both beat expectations.

For FY2024, all-in sales growth is expected to be 2-4% while organic sales growth is expected to be 4-5%.

ADVERTISEMENT

The stock gained over 1% in premarket hours on Wednesday.  

Prior performance

ADVERTISEMENT